Swedish Orphan Biovitrum Ab (BIOVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -224,599 | 195,615 | 102,805 | 416,902 | 285,024 |
| Depreciation Amortization | 981,844 | 189,095 | 87,984 | 348,033 | 263,712 |
| Other Working Capital | -77,669 | 86,319 | 96,051 | -17,028 | -5,088 |
| Other Operating Activity | -92,698 | -83,628 | -71,569 | -49,003 | -6,912 |
| Operating Cash Flow | $586,878 | $387,401 | $215,271 | $698,905 | $536,736 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,679 | -2,795 | -657 | -16,082 | -7,200 |
| Purchase Of Investment | -4,099 | -3,105 | -3,471 | N/A | -3,840 |
| Purchase Sale Intangibles | -323,918 | -41,918 | -375 | -268,191 | -276,000 |
| Other Investing Activity | -330,329 | -47,817 | -4,690 | -276,327 | -276,000 |
| Investing Cash Flow | $-338,107 | $-53,717 | $-8,817 | $-292,409 | $-287,040 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -302,268 | N/A | N/A | 1,345,212 | -296,832 |
| Debt Repayment | N/A | -380,673 | -220,242 | -1,764,858 | N/A |
| Common Stock Issued | 4,835 | 3,830 | 281 | 40,394 | 40,896 |
| Other Financing Activity | 42,671 | 37,260 | 4,878 | 757 | -17,760 |
| Financing Cash Flow | $-254,762 | $-339,584 | $-215,083 | $-378,495 | $-273,696 |
| Exchange Rate Effect | -4,414 | -2,588 | -4,690 | -5,771 | -5,760 |
| Beginning Cash Position | 119,814 | 117,990 | 106,932 | 85,518 | 86,784 |
| End Cash Position | 109,199 | 109,503 | 93,519 | 107,844 | 57,024 |
| Net Cash Flow | $-10,615 | $-8,487 | $-13,413 | $22,326 | $-29,760 |
| Free Cash Flow | |||||
| Operating Cash Flow | 586,878 | 387,401 | 215,271 | 698,905 | 536,736 |
| Capital Expenditure | -3,679 | -2,795 | -657 | -16,082 | -7,200 |
| Free Cash Flow | 583,200 | 384,606 | 214,614 | 682,823 | 529,536 |